TGFB1 and breast cancer: In their most recent study, Melzer et al. showed how coculturing MSCs with malignant breast cancer cells causes changes in the synthesis of urokinase plasminogen activator (uPA), plasminogen activator inhibitor type-1 (PAI-1), and TGF-β, which may encourage ongoing tumor development.